Rhythm Pharmaceuticals buy Citigroup Inc.
Start price
27.11.25
/
50%
€93.00
Target price
27.11.26
€117.12
Performance (%)
-20.97%
Price
24.04.26
€72.00
Summary
This prediction is currently active. The price of Rhythm Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.97%. This prediction currently runs until 27.11.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -4.000% | -4.000% |
| iShares Core DAX® | -1,74 % | 5,98 % |
| iShares Nasdaq 100 | 2,81 % | 11,83 % |
| iShares Nikkei 225® | -0,11 % | 11,69 % |
| iShares S&P 500 | 0,97 % | 7,62 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $136.00 price target on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
17.03.26
17.03.26
€113.94
17.03.27
17.03.27
-5.16%
24.04.26
24.04.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€83.00
25.09.25
25.09.25
-
25.09.26
25.09.26
-13.25%
24.04.26
24.04.26